levodopa has been researched along with Malnutrition in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 6 (66.67) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Fu, J; Li, Z; Wang, F; Yu, K | 1 |
Budrewicz, S; Koszewicz, M; Koziorowska-Gawron, E; Rączka, D; Szczepańska, A; Słotwiński, K; Zmarzły, A | 1 |
Bentivoglio, AR; Bernabei, R; Franceschi, F; Laudisio, A; Meloni, E; Ricciardi, D; Vetrano, DL; Zuccalà, G | 1 |
Barichella, M; Bolliri, C; Caronni, S; Cassani, E; Cereda, E; Faierman, SA; Ferri, V; Frazzitta, G; Iorio, L; Lignola, C; Lubisco, A; Monajemi, F; Pasqua, M; Petroni, ML; Pezzoli, G; Pinelli, G; Privitera, G; Pusani, C; Valentino, A | 1 |
Bäckman, L; Håglin, L | 1 |
Marín, E; Uribe, M | 1 |
Jugel, C; Klostermann, F; Marzinzik, F; Müller, T | 1 |
Barichella, M; Caccialanza, R; Cancello, R; Cassani, E; Cereda, E; Iorio, L; Madio, C; Pezzoli, G; Pusani, C | 1 |
Dulloo, AG; Montani, JP | 1 |
2 review(s) available for levodopa and Malnutrition
Article | Year |
---|---|
Prevalence of malnutrition/malnutrition risk and nutrition-related risk factors among patients with Parkinson's disease: systematic review and meta-analysis.
Topics: Humans; Levodopa; Malnutrition; Nutrition Assessment; Nutritional Status; Parkinson Disease; Prevalence; Risk Factors | 2022 |
Treatment of portal systemic encephalopathy: standard and new treatments.
Topics: Bromocriptine; Clinical Trials as Topic; Colon; Dietary Proteins; Disaccharides; Double-Blind Method; Enema; GABA Antagonists; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hyperammonemia; Laxatives; Levodopa; Liver Cirrhosis; Malnutrition; Metabolic Networks and Pathways; Plant Proteins, Dietary; Sodium Benzoate; Zinc | 1990 |
7 other study(ies) available for levodopa and Malnutrition
Article | Year |
---|---|
Clinical and nutritional correlations in Parkinson's disease: Preliminary report.
Topics: Aged; Antiparkinson Agents; Body Mass Index; Female; Humans; Levodopa; Male; Malnutrition; Middle Aged; Nutritional Status; Parkinson Disease; Severity of Illness Index | 2019 |
Dopaminergic agents and nutritional status in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Dopamine Agents; Female; Humans; Levodopa; Male; Malnutrition; Middle Aged; Nutritional Status; Parkinson Disease | 2014 |
Dietary habits and neurological features of Parkinson's disease patients: Implications for practice.
Topics: Aged; Antiparkinson Agents; Case-Control Studies; Constipation; Cross-Sectional Studies; Diet, Healthy; Energy Intake; Feeding Behavior; Female; Food-Drug Interactions; Hospitals, Special; Humans; Italy; Levodopa; Male; Malnutrition; Middle Aged; Outpatient Clinics, Hospital; Parkinson Disease; Patient Compliance; Prevalence; Risk; Severity of Illness Index | 2017 |
Covariation between plasma phosphate and daytime cortisol in early Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Case-Control Studies; Circadian Rhythm; Cognition; Female; Humans; Hydrocortisone; Levodopa; Logistic Models; Male; Malnutrition; Middle Aged; Nutrition Assessment; Parkinson Disease; Phosphates; Serum Albumin; Transferrin | 2016 |
Malnutritional neuropathy under intestinal levodopa infusion.
Topics: Aged; Carbidopa; Humans; Infusions, Parenteral; Levodopa; Male; Malnutrition; Middle Aged; Neurotoxicity Syndromes; Parkinson Disease; Polyneuropathies | 2012 |
Nutritional risk and gastrointestinal dysautonomia symptoms in Parkinson's disease outpatients hospitalised on a scheduled basis.
Topics: Aged; Confidence Intervals; Constipation; Deglutition Disorders; Female; Gastrointestinal Diseases; Hospitalization; Humans; Levodopa; Male; Malnutrition; Middle Aged; Nutritional Status; Odds Ratio; Outpatients; Parkinson Disease; Prevalence; Primary Dysautonomias; Risk Factors; Severity of Illness Index; Sialorrhea; Weight Loss | 2013 |
Obesity in Parkinson's disease patients on electrotherapy: collateral damage, adiposity rebound or secular trends?
Topics: Antiparkinson Agents; Body Mass Index; Brain; Combined Modality Therapy; Dopamine; Electric Stimulation Therapy; Humans; Levodopa; Malnutrition; Obesity; Parkinson Disease; Receptors, Dopamine D2; Subthalamic Nucleus | 2005 |